Your browser doesn't support javascript.
loading
Recurrent mutations refine prognosis in chronic lymphocytic leukemia.
Baliakas, P; Hadzidimitriou, A; Sutton, L-A; Rossi, D; Minga, E; Villamor, N; Larrayoz, M; Kminkova, J; Agathangelidis, A; Davis, Z; Tausch, E; Stalika, E; Kantorova, B; Mansouri, L; Scarfò, L; Cortese, D; Navrkalova, V; Rose-Zerilli, M J J; Smedby, K E; Juliusson, G; Anagnostopoulos, A; Makris, A M; Navarro, A; Delgado, J; Oscier, D; Belessi, C; Stilgenbauer, S; Ghia, P; Pospisilova, S; Gaidano, G; Campo, E; Strefford, J C; Stamatopoulos, K; Rosenquist, R.
Afiliación
  • Baliakas P; 1] Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden [2] Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.
  • Hadzidimitriou A; 1] Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden [2] Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Sutton LA; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Rossi D; Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Minga E; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Villamor N; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Larrayoz M; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Kminkova J; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Agathangelidis A; 1] Università Vita-Salute San Raffaele, Milan, Italy [2] Division of Molecular Oncology and Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy.
  • Davis Z; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Tausch E; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Stalika E; Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.
  • Kantorova B; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Mansouri L; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Scarfò L; 1] Università Vita-Salute San Raffaele, Milan, Italy [2] Division of Molecular Oncology and Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy.
  • Cortese D; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
  • Navrkalova V; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Rose-Zerilli MJ; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Smedby KE; Department of Medicine, Solna, Clinical Epidemiology Unit, Karolinska Institutet, Stockholm, Sweden.
  • Juliusson G; Lund University and Hospital Department of Hematology, Lund Stem Cell Center, Lund, Sweden.
  • Anagnostopoulos A; Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.
  • Makris AM; Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Navarro A; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Delgado J; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Oscier D; Department of Haematology, Royal Bournemouth Hospital, Bournemouth, UK.
  • Belessi C; Hematology Department, Nikea General Hospital, Pireaus, Greece.
  • Stilgenbauer S; Department of Internal Medicine III, Ulm University, Ulm, Germany.
  • Ghia P; 1] Università Vita-Salute San Raffaele, Milan, Italy [2] Division of Molecular Oncology and Department of Onco-Hematology, San Raffaele Scientific Institute, Milan, Italy.
  • Pospisilova S; Central European Institute of Technology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
  • Gaidano G; Division of Haematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy.
  • Campo E; Hematopathology Unit and Department of Hematology, Hospital Clinic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi iSunyer (IDIBAPS), Barcelona, Spain.
  • Strefford JC; Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Stamatopoulos K; 1] Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden [2] Hematology Department and HCT Unit, G Papanicolaou Hospital, Thessaloniki, Greece [3] Institute of Applied Biosciences, CERTH, Thessaloniki, Greece.
  • Rosenquist R; Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
Leukemia ; 29(2): 329-36, 2015 Feb.
Article en En | MEDLINE | ID: mdl-24943832
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Leucemia Linfocítica Crónica de Células B / Mutación Tipo de estudio: Prognostic_studies Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Leukemia Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Grecia Pais de publicación: Reino Unido